MetLife Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $96K | Sell |
|
|||||
|
2025
Q2 | $109K | Buy |
|
|||||
|
2025
Q1 | $162K | Sell |
|
|||||
|
2024
Q4 | $143K | Hold |
|
|||||
|
2024
Q3 | $155K | Hold |
|
|||||
|
2024
Q2 | $95K | Buy |
|
|||||
|
2024
Q1 | $81.1K | Buy |
|
|||||
|
2023
Q4 | $86.6K | Hold |
|
|||||
|
2023
Q3 | $165K | Hold |
|
|||||
|
2023
Q2 | $207K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $63.6K | Sell |
|
|||||
|
2021
Q4 | $74.9K | Buy |
|
|||||
|
2021
Q3 | $82.7K | Sell |
|
|||||
|
2021
Q2 | $216K | Buy |
|